Continuing to improve outcomes of men with metastatic prostate cancer
Crossref DOI link: https://doi.org/10.1038/s41571-019-0254-9
Published Online: 2019-07-16
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saad, Fred
Text and Data Mining valid from 2019-07-16
Version of Record valid from 2019-07-16
Article History
First Online: 16 July 2019
Competing interests
: F.S. is a paid consultant for and receives research funding from Astellas, Bayer, Janssen and Sanofi.